Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.9%

5 terminated/withdrawn out of 72 trials

Success Rate

88.1%

+1.6% vs industry average

Late-Stage Pipeline

14%

10 trials in Phase 3/4

Results Transparency

11%

4 of 37 completed trials have results

Key Signals

11 recruiting4 with results

Enrollment Performance

Analytics

Phase 2

24(38.7%)

N/A

17(27.4%)

Phase 1

9(14.5%)

Phase 4

6(9.7%)

Phase 3

4(6.5%)

Early Phase 1

2(3.2%)

62Total

Phase 2(24)

N/A(17)

Phase 1(9)

Phase 4(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials

NCT07712770Early Phase 1Not Yet Recruiting

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

Role: collaborator

NCT07634289Phase 2Not Yet Recruiting

Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Role: collaborator

NCT05169177Recruiting

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

Role: collaborator

NCT05184790Recruiting

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Role: collaborator

NCT07019493Recruiting

Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Role: collaborator

NCT07535580Not ApplicableCompleted

Patient-Reported Stent Symptom Outcomes and Migration Rates Following Modified Single-J Ureteric Stent Insertion After Ureteroscopy

Role: lead

NCT04075305Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Role: collaborator

NCT07225465Phase 2Not Yet Recruiting

Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin

Role: collaborator

NCT07017686Not ApplicableRecruiting

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Role: collaborator

NCT05788081Phase 2Active Not Recruiting

Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

Role: collaborator

NCT05899985Not ApplicableRecruiting

Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation

Role: collaborator

NCT06871254Not ApplicableRecruiting

Spinal Cord Injury Neurorecovery Collaboration

Role: collaborator

NCT07079007Not Yet Recruiting

Use of Water Ingestion in Small Intestine Ultrasound

Role: lead

NCT06916819Not ApplicableRecruiting

Food Challenge at Home or in Medical Practice - the FoodCHOMP Study

Role: lead

NCT04962126Phase 2Active Not Recruiting

Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy

Role: collaborator

NCT02770040Phase 4Completed

Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis

Role: lead

NCT06279260Recruiting

National Robotics-Assisted Radical Prostatectomy Database

Role: collaborator

NCT03244176Early Phase 1Active Not Recruiting

Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study

Role: lead

NCT03610061Phase 1Completed

A Trial of Radiotherapy and Durvalumab in DLBCL and FL

Role: lead

NCT04901234Phase 2Recruiting

Adaptive RadioTherapy for OroPharynx Cancer

Role: collaborator